Cytosorbents Corporation (CTSO)
NASDAQ · Healthcare
Cytosorbents Corporation annual/quarterly shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Cytosorbents Corporation shareholder equity for the quarter ending December 31, 2025 were 5.9M, a 46.85% decrease year-over-year.
- Cytosorbents Corporation shareholder equity for 2025 were 5.9M, a 46.85% decrease from 2024.
- Cytosorbents Corporation shareholder equity for 2024 were 11.1M, a 52.70% decrease from 2023.
- Cytosorbents Corporation shareholder equity for 2023 were 23.5M, a 33.63% decrease from 2022.
- Cytosorbents Corporation shareholder equity for 2022 were 35.4M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cytosorbents Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $6 |
| 2024 | $11 |
| 2023 | $23 |
| 2022 | $35 |
| 2021 | $63 |
| 2020 | $79 |
| 2019 | $3 |
| 2018 | $17 |
| 2017 | $10 |
| 2016 | $1 |
| 2015 | $10 |
| 2014 | $7 |
| 2013 | $-14 |
| 2012 | $-12 |
| 2011 | $-10 |
| Cytosorbents Corporation Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $6 |
| 2024-12-31 | $11 |
| 2023-12-31 | $23 |
| 2022-12-31 | $35 |
| 2021-12-31 | $63 |
| 2020-12-31 | $79 |
| 2019-12-31 | $3 |
| 2018-12-31 | $17 |
| 2017-12-31 | $10 |
| 2016-12-31 | $1 |
| 2015-12-31 | $10 |
| 2014-12-31 | $7 |
| 2013-12-31 | $-14 |
| 2012-12-31 | $-12 |
| 2011-12-31 | $-10 |
Cytosorbents Corporation Shareholder Equity — FAQ
Cytosorbents Corporation (CTSO) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTSO's shareholder equity history?
The chart and table above show Cytosorbents Corporation's shareholder equity by year and by quarter, including the growth rate.